The MACH37 Cyber Accelerator program lasts for 90 days and is composed of startups that are cultivated from the area’s best and brightest and they are instructed on the various facets of starting and sustaining a successful business. The first session was held in September of 2013 and since then there have been five classes and 29 new cyber security companies have been launched as a result.
AstraZeneca confirmed Monday morning that it is “exploring potential strategic options” with Acerta Pharma BV.
Acerta is a privately held biopharmaceutical company with offices in California and The Netherlands. Its lead product is an experimental blood cancer drug, called acalabrutinib, which is in late-stage clinical testing.
Amidst the rhetoric of Campaign 2016, the reality of escalating health costs, and the acceleration of consolidation across the industry, healthcare headlines in 2016 will highlight major changes that will reshape the future for the next decade and beyond.
Here’s the top 10 you can expect to read next year:
Gaithersburg-based biotech WellStat Therapeutics Corp. received Food and Drug Administration approval for Vistogard, an emergency treatment for an overdose of certain chemotherapy drugs, it was announced Friday.
It is the second FDA approval the company has received for one of its drugs this fall.
Prince William County is in a race to establish itself as the center of bioscience research and commercialization and it’s making progress. The county’s science accelerator, established two years ago, now has three companies and will add two more in the next few months. Prince William’s head of economic development, Jeff Kaczmarek, says the accelerator is aiming to be at full capacity by the end of next year, as more companies take up its 9,100 SF, which is the only commercially available wet lab space in the region.
Dr Martine Rothblatt and Cyndi Lauper were the recipients of this year’s Billie Jean King Leadership Initiative (BJKLI) awards on Wednesday night.
The tennis legend launched the non-profit BJKLI in 2014 with her partner, Ilana Kloss, to promote and celebrate inclusive leadership. This year’s awards gala, in partnership with Teneo, took place Wednesday night at World Trade Center 4 in New York.
AstraZeneca and its global biologics research and development arm, MedImmune, today announced a three-year collaboration with the newly established Wallenberg Centre for Protein Research (WCPR). The collaboration aims to develop new technologies for biologics production and to identify new targets for disease research in the ground-breaking area of the Secretome – research into all proteins that are secreted by a cell or that are exposed to the outside of the cell from within the cell membrane.
Although the University System of Maryland, at its core, is a collection of 12 colleges, new Chancellor Bob Caret says he sees it as a business — a business that the state needs to invest in. Caret said that for every $1 the state spends on USM, he can bring the state back $6.
U.S. health regulators on Friday said they have granted accelerated approval to Roche Holding’s drug for advanced lung cancer in patients with a specific genetic mutation.
The drug, alectinib, to be sold under the brand name Alecensa, was approved to treat patients with advanced ALK-positive non-small cell lung cancer (NSCLC) whose disease has worsened after, or who could not tolerate, treatment with Pfizer’s Xalkori.
Becton, Dickinson and Company (BDX), or BD, operated under three business segments until 2014. It then underwent organizational restructuring, effective October 1, 2015, to better align its business model to the strategic vision and goals of the company. Consequently, the company operates under two business segments: BD Medical and BD Life Sciences.
